1. Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine-induced killer cell therapy in hepatobiliary and pancreatic cancer
   LIHONG ZHANG et al, 2016, Molecular and Clinical Oncology CrossRef
2. A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks
   Pierangela Palmerini et al, 2020, Cytotherapy CrossRef
3. CIK as therapeutic agents against tumors
   M. Introna, 2017, Journal of Autoimmunity CrossRef
4. Innovative Clinical Perspectives for CIK Cells in Cancer Patients
   Martino Introna et al, 2018, International Journal of Molecular Sciences CrossRef
5. Umbilical cord blood–derived cellular products for cancer immunotherapy
   Jeannette Cany et al, 2015, Cytotherapy CrossRef
6. Cord blood–derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors
   JOSÉE GOLAY et al, 2018, Cytotherapy CrossRef
7. Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?
   Caroline Lonez et al, 2024, Cells CrossRef
8. The possible molecular regulation mechanism of CIK cells inhibiting the proliferation of Human Lung Adenocarcinoma NCL-H157 Cells
   Dengrui Li et al, 2016, Open Medicine CrossRef
9. The Immune Regulatory Role of Cytokine-Induced Killer Cells Treatment on Non-Small Cell Lung Cancer Patients
   Li Zhang et al, 2018, Lung Cancer - Strategies for Diagnosis and Treatment CrossRef
10. Clinical Trials with Cytokine-Induced Killer Cells and CAR-T Cell Transplantation for Non-small Cell Lung Cancer Treatment
    Le Van Manh Hung et al, 2020, Cancer Biology and Advances in Treatment CrossRef
11. Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives
    Bilal Zulfiqar et al, 2022, Frontiers in Pharmacology CrossRef
12. How can Cytokine-induced killer cells overcome CAR-T cell limits
    Elisa Cappuzzello et al, 2023, Frontiers in Immunology CrossRef